Beginning biologic therapy within 12 months of Crohn’s disease diagnosis leads to higher rates of transmural healing, according to a study conducted in Europe.
These findings provide further support for transmural healing as a valuable therapeutic target in CD, said lead investigator Joana Revés, MD, a resident in the gastroenterology department at Hospital Beatriz Ângelo, in Loures, Portugal.
The retrospective multicenter study included 154 patients who were diagnosed with CD